Samsung Biologics

Samsung Biologics is one of the world’s largest biotech-focused CDMOs, with more than 3,400 employees across sites in Republic of Korea and the US. Founded in 2011, it is the biotech division of Samsung Group. It has a track-record of successful regulatory approvals, large capacity and rapid throughput.